Virgin Galactic Announces Fourth Quarter and Full Year 2020 Financial Results
02/25/2021 - 04:05 PM
Virgin Galactic Holdings, Inc. (NYSE: SPCE) (“Virgin Galactic” or the “Company”), a vertically integrated aerospace and space travel company, today announced its financial results for the fourth quarter and full year ended December 31, 2020.
“We accomplished several significant milestones during 2020 despite the ongoing challenges posed by the COVID-19 pandemic,” said Michael Colglazier, Chief Executive Officer of Virgin Galactic. “Looking ahead, we’re focused on completing our test flight program, expanding our fleet of spaceships and motherships, and developing our unique and transformative customer experience. I am excited about the talent we’re bringing on to our leadership team and the investments we’re making in the business, both of which will position us well to scale for future growth.”
Fourth Quarter 2020 Business Highlights:
Completed significant build milestones on second spaceship, in preparation for its scheduled rollout on March 30, 2021.
Conducted safe test flight on December 12, 2020 during which the onboard computer lost connection and halted ignition of the rocket motor.
Appointed two new pilots into Virgin Galactic Pilot Corps, bringing the total number of pilots to eight as of October 27, 2020.
Successfully closed the “One Small Step” program on December 31, 2020, with approximately 1,000 participants enrolled.
Total Future Astronauts remained at approximately 600, as of December 31, 2020.
Appointed Alistair Burns as Chief Information Officer on November 9, 2020.
Fourth Quarter 2020 Financial Highlights:
Cash position remains strong, with cash and cash equivalents of $666 million as of December 31, 2020.
Net loss of $74 million , compared to a $77 million net loss in the third quarter of 2020.
GAAP selling, general, and administrative expenses of $33 million , compared to $31 million in the third quarter of 2020. Non-GAAP selling, general and administrative expenses of $23 million in the fourth quarter of 2020, compared to $26 million in the third quarter of 2020.
GAAP research and development expenses of $41 million , compared to $46 million in the third quarter of 2020. Non-GAAP research and development expenses of $40 million in the fourth quarter of 2020, compared to $43 million in the third quarter of 2020.
Adjusted EBITDA totaled $(60) million , compared to $(66) million in the third quarter of 2020.
Cash paid for capital expenditures totaled $3.5 million , compared to $3.7 million in the third quarter of 2020.
Recent Updates:
Continue to prepare for next rocket-powered spaceflight from Spaceport America, targeted for May 2021. Completing modifications and conducting technical checks ahead of flight, which will include revenue-generating payloads as part of the NASA Flight Opportunities Program.
Re-confirmed second and third spaceflights from Spaceport America, including Sir Richard Branson’s flight, and announced timing for revenue-generating spaceflight with the Italian Air Force.
Accelerating multi-month enhancement program to mothership vehicle, VMS Eve, and preparing for second generation mothership build program.
Continue to build senior management team:
Appointed Swami Iyer as President of Aerospace Systems, effective end of March 2021.
Appointed Stephen Justice as Vice President of Engineering on March 1, 2021.
Appointed Doug Ahrens as Chief Financial Officer, effective March 1, 2021.
Appointed Seth Zaslow as Vice President of Investor Relations on February 8, 2021.
COVID-19 Impact
The Company is continuing to experience ongoing delays to its business and operations due to COVID-19. The Company continues to operate under strict protocols and follows rigorous health and safety procedures, in line with CDC, state and local guidelines, to ensure employee safety.
Conference Call Information
Virgin Galactic will host a conference call to discuss the results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) today. To access the conference call, parties should dial (778) 560-2846 and enter the conference ID number 4979998. The live audio webcast along with accompanying presentation materials will be accessible on the Company’s Investor Relations website at investors.virgingalactic.com . A recording of the webcast will also be available following the conference call.
About Virgin Galactic Holdings
Virgin Galactic Holdings, Inc. is a vertically integrated aerospace and space travel company, pioneering human spaceflight for private individuals and researchers, as well as a manufacturer of advanced air and space vehicles. It is developing a spaceflight system designed to offer customers a unique and transformative experience. You can find more information at https://www.virgingalactic.com/ .
Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of federal securities laws with respect to Virgin Galactic Holdings, Inc. (the "Company"), including statements regarding the Company’s expected spaceship rollout and flight schedule. These forward-looking statements generally are identified by words such as “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this presentation, including but not limited to the factors, risks and uncertainties included in the Company’s filings with the Securities and Exchange Commission (the “SEC”), including, once filed, its Annual Report on Form 10-K for the fiscal year ended December 31, 2020, which are or will be accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at www.virgingalactic.com . These filings identify and address other important risks and uncertainties that could cause the Company’s actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
Fourth Quarter 2020 Financial Results
VIRGIN GALACTIC HOLDINGS, INC.
Condensed Consolidated Statements of Operations and Comprehensive Loss
(In thousands except for per share data)
Three Months Ended
Year Ended
(unaudited)
(unaudited)
December 31,
September 30,
December 31,
December 31,
December 31,
Revenue
$
—
$
—
$
529
$
238
$
3,781
Cost of revenue
—
—
314
173
2,004
Gross profit
—
—
215
65
1,777
Selling, general, and administrative expenses
32,854
30,936
37,447
116,592
82,166
Research and development expenses1
41,463
46,095
36,754
158,757
132,873
Operating loss
(74,317
)
(77,031
)
(73,986
)
(275,284
)
(213,262
)
Interest income
272
322
1,160
2,277
2,297
Interest expense
(10
)
(9
)
(34
)
(36
)
(36
)
Other income (expense)
9
(44
)
—
14
128
Loss before income taxes
(74,046
)
(76,762
)
(72,860
)
(273,029
)
(210,873
)
Income tax (benefit) expense
(28
)
40
(61
)
6
62
Net loss
(74,018
)
(76,802
)
(72,799
)
(273,035
)
(210,935
)
Other comprehensive loss:
Foreign currency translation adjustment
(48
)
48
56
(54
)
(23
)
Total comprehensive loss
$
(74,066
)
$
(76,754
)
$
(72,743
)
$
(273,089
)
$
(210,958
)
Net loss per share:
Basic and diluted
$
(0.31
)
$
(0.34
)
$
(0.37
)
$
(1.25
)
$
(1.09
)
Weighted-average shares outstanding:
Basic and diluted
236,722,884
225,253,536
194,378,154
219,107,905
194,378,154
1 Please refer to Reclassification section for prior period adjustment.
VIRGIN GALACTIC HOLDINGS, INC.
Condensed Consolidated Balance Sheets
(In thousands, except share data)
As of
December 31,
December 31,
(unaudited)
Assets
Current assets
Cash and cash equivalents
$
665,924
$
480,443
Restricted cash
13,031
12,278
Accounts receivable
470
461
Inventories1
30,483
31,855
Prepaid expenses and other current assets
17,949
16,672
Due from related party, net
70
—
Total current assets
727,927
541,709
Property, plant, and equipment, net1
53,148
44,295
Right-of-use asset
19,914
16,927
Other non-current assets
3,001
2,615
Total assets
$
803,990
$
605,546
Liabilities and Stockholders' Equity
Current liabilities
Accounts payable
$
5,998
$
7,038
Current portion of operating lease obligation
2,384
2,354
Current portion of finance lease obligation
136
47
Current portion of note payable
310
—
Accrued expenses
22,982
22,277
Customer deposits
83,211
83,362
Due to related party, net
—
767
Total current liabilities
115,021
115,845
Finance lease obligation, net of current portion
236
274
Operating lease obligation, net of current portion
24,148
21,867
Note payable, net of current portion
310
—
Other long-term liabilities
1,757
—
Total liabilities
$
141,472
$
137,986
Stockholders' Equity
Preferred stock, $0.0001 par value; 10,000,000 authorized; none issued and outstanding
$
—
$
—
Common stock, $0.0001 par value; 700,000,000 shares authorized; 236,123,659 and 196,001,038 shares issued and outstanding as of December 31, 2020 and 2019, respectively
23
20
Additional paid-in capital
1,057,202
589,158
Accumulated deficit
(394,712)
(121,677)
Accumulated other comprehensive income
5
59
Total stockholders' equity
662,518
467,560
Total liabilities and stockholders' equity
$
803,990
$
605,546
1 Please refer to Reclassification section for prior period adjustment.
VIRGIN GALACTIC HOLDINGS, INC.
Condensed Consolidated Statements of Cash Flows
(In thousands)
Three Months Ended
Year Ended
(unaudited)
(unaudited)
December
September
December
December
December
Cash flows from operating activities
Net loss
$
(74,018
)
$
(76,802
)
$
(72,799
)
$
(273,035
)
$
(210,935
)
Stock-based compensation
11,749
8,625
2,535
30,324
2,535
Depreciation and amortization
2,765
2,529
2,079
9,781
6,999
Deferred rent
—
—
375
—
—
(Gain) Loss on disposal of property and equipment1
21
8
(555
)
96
(555
)
Change in assets and liabilities
Accounts receivable
(100
)
414
431
(106
)
819
Inventories1
176
3,182
(6,256
)
1,371
(8,566
)
Prepayments and other current assets
(8,674
)
4,724
(13,089
)
(342
)
(12,476
)
Other non-current assets
47
(1,251
)
8,107
(1,131
)
1,178
Due from related party, net
158
(996
)
9,734
(838
)
9,734
Accounts payable and accrued expenses
(1,729
)
1,633
(2,883
)
(1,010
)
(323
)
Customer deposits
21
1,456
1,160
(151
)
2,479
Other current and non-current liabilities
(512
)
1,502
(9,664
)
1,882
—
Net cash used in operating activities
(70,096
)
(54,976
)
(80,825
)
(233,159
)
(209,111
)
Cash flows from investing activity
Capital expenditures1
(3,540
)
(3,721
)
(176
)
(17,201
)
(13,856
)
Cash used in investing activity1
(3,540
)
(3,721
)
(176
)
(17,201
)
(13,856
)
Cash flows from financing activities
Payments of finance lease obligations
(34
)
(40
)
(49
)
(123
)
(104
)
Repayment of notes payable
(310
)
—
—
(310
)
—
Net transfer from Parent Company
—
—
—
—
106,119
Proceeds from Parent Company
—
—
16,310
—
56,310
Proceeds from issuance of common stock pursuant to stock options exercised
2,582
—
—
2,582
—
Proceeds from issuance of common stocks
—
460,200
20,000
460,200
20,000
Proceeds from reverse acquisition
—
—
500,000
—
500,000
Transaction costs
(122
)
(19,399
)
(48,005
)
(20,988
)
(48,005
)
Withholding taxes paid on behalf of employee on net settled stock-based awards
(4,368
)
(399
)
—
(4,767
)
—
Net cash provided by (used in) by financing activities
(2,252
)
440,362
488,256
436,594
634,320
Net increase (decrease) in cash and cash equivalents1
(75,888
)
381,665
407,255
186,234
411,353
Cash, cash equivalents and restricted cash at beginning of period
754,843
373,178
85,466
492,721
81,368
Cash, cash equivalents and restricted cash at end of period
$
678,955
$
754,843
$
492,721
$
678,955
$
492,721
Cash and cash equivalents
$
665,924
$
741,575
$
480,443
$
665,924
$
480,443
Restricted cash
13,031
13,268
12,278
13,031
12,278
Cash, cash equivalents and restricted cash
$
678,955
$
754,843
$
492,721
$
678,955
$
492,721
1 Please refer to Reclassification section for prior period adjustment.
Use of Non-GAAP Financial Measures (Unaudited)
This press release references certain financial measures that are not prepared in accordance with generally accepted accounting principles in the United States (GAAP), including Adjusted EBITDA, non-GAAP selling, general, and administrative expense and non-GAAP research and development expense. The Company defines Adjusted EBITDA as earnings before interest expense, taxes, depreciation and amortization, stock-based compensation, and certain other items the Company believes are not indicative of its core operating performance. It defines non-GAAP selling, general, and administrative expenses as selling, general, and administrative expenses other than stock-based compensation and non-capitalized transaction costs, and non-GAAP research and development expenses as research and development expenses other than stock-based compensation. None of these non-GAAP financial measures is a substitute for or superior to measures of financial performance prepared in accordance with GAAP and should not be considered as an alternative to any other performance measures derived in accordance with GAAP.
The Company believes that presenting these non-GAAP financial measures provides useful supplemental information to investors about the Company in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by its management in financial and operational-decision making. However, there are a number of limitations related to the use of non-GAAP measures and their nearest GAAP equivalents. For example, other companies may calculate non-GAAP measures differently, or may use other measures to calculate their financial performance, and therefore any non-GAAP measures the Company uses may not be directly comparable to similarly titled measures of other companies.
A reconciliation of Adjusted EBITDA to net loss for the three months ended December 31, 2020, September 30, 2020, December 31, 2019 and years ended December 31, 2020 and 2019, respectively, are set forth below:
(In thousands)
Three Months Ended
Year Ended
December
September
December
December
December
Net Loss
$
(74,018
)
$
(76,802
)
$
(72,799
)
$
(273,035
)
$
(210,935
)
Income tax (benefit) expense
(28
)
40
(61
)
6
62
Interest expense
10
9
34
36
36
Depreciation & amortization
2,765
2,529
2,079
9,781
6,999
EBITDA
(71,271
)
(74,224
)
(70,747
)
(263,212
)
(203,838
)
Cash Incentive Plan Disbursement
9,867
9,867
Non-capitalized transaction costs*
—
—
3,577
697
4,692
Stock-based compensation
11,749
8,625
2,535
30,324
2,535
Adjusted EBITDA
$
(59,522
)
$
(65,599
)
$
(54,768
)
$
(232,191
)
$
(186,744
)
A reconciliation of selling, general, and administrative expenses to non-GAAP selling, general, and administrative expenses for the three months ended December 31, 2020, September 30, 2020, December 31, 2019 and years ended December 31, 2020 and 2019, respectively, are set forth below:
(In thousands)
Three Months Ended
Year Ended
December
September
December
December
December
Selling, general, and administrative expenses
$
32,854
$
30,936
$
37,447
$
116,592
$
82,166
Cash Incentive Plan Disbursement
—
—
9,867
—
9,867
Stock-based compensation
9,800
5,056
1,591
21,272
1,591
Non-capitalized transaction costs*
—
—
3,577
697
4,692
Non-GAAP selling, general,
$
23,054
$
25,880
$
22,412
$
94,623
$
66,016
A reconciliation of research and development expenses to non-GAAP research and development expenses for the three months ended December 31, 2020, September 30, 2020, December 31, 2019 and years ended December 31, 2020 and 2019, respectively, are set forth below:
(In thousands)
Three Months Ended
Year Ended
December
September
December
December
December
Research and development expenses
$
41,463
$
46,095
$
36,754
$
158,757
$
132,873
Stock-based compensation
1,949
3,569
944
9,052
944
Non-GAAP Research and
$
39,514
$
42,526
$
35,810
$
149,705
$
131,929
_______________
*Non-capitalized transaction costs include non-recurring expenses related to preparation and filing of an S-1 registration statement in the first quarter of 2020.
Reclassification Adjustments Impacting Prior Periods
During the year ended December 31, 2020, we reclassified a portion of our property, plant and equipment in machinery and equipment to inventory, as part of our standardization of accounting policies across entities, for inventory and property, plant and equipment. These reclassifications impacted our consolidated balance sheets, consolidated statements of operations and consolidated statements of cash flows, as set forth below:
(In thousands)
December 31,
As Reported
Reclassification
December 31,
As Adjusted
Balance Sheet
Inventories
$
26,817
$
5,038
$
31,855
Total Current assets
536,671
5,038
541,709
Property, plant and equipment, net
49,333
(5,038
)
44,295
Total assets
605,546
—
605,546
Statement of Cash Flows - for the year ended
(Gain) loss on disposal of property, plant and equipment
(38
)
(517
)
(555
)
Inventories
(3,528
)
(5,038
)
(8,566
)
Net cash used in operating activities
(203,556
)
(5,555
)
(209,111
)
Capital expenditures
(19,411
)
5,555
(13,856
)
Cash (used in) provided by investing activity
(19,411
)
5,555
(13,856
)
Net increase in cash and cash equivalents
$
411,353
$
—
$
411,353
(In thousands)
September 30,
As Reported
Reclassification
September 30,
As Adjusted
Statement of Operations and Comprehensive Loss - for the three months ended
Research and development expenses
$
46,243
$
(148
)
$
46,095
Operating Loss
(77,179
)
148
(77,031
)
Loss before income taxes
(76,910
)
148
(76,762
)
Net Loss
(76,950
)
148
(76,802
)
Total comprehensive loss
$
(76,902
)
$
148
$
(76,754
)
Statement of Cash Flows - for the three months ended
Net loss
$
(76,950
)
$
148
$
(76,802
)
Depreciation and amortization
2,677
(148
)
2,529
Inventories
3,457
(275
)
3,182
Net cash used in operating activities
(54,701
)
(275
)
(54,976
)
Capital expenditures
(3,996
)
275
(3,721
)
Cash (used in) provided by investing activity
(3,996
)
275
(3,721
)
Net increase in cash and cash equivalents
$
381,665
$
—
$
381,665
View source version on businesswire.com: https://www.businesswire.com/news/home/20210225006120/en/
